Toward a new blood vessel

Strategies to treat atherosclerotic coronary artery disease include coronary artery bypass grafting (CABG), in which grafts are used to bypass atherosclerotic vessels and restore blood flow to the ischemic myocardium. The grafts used include healthy arteries or veins harvested from a separate site. Results with arterial grafts have been superior to venous grafts; promoting the practice of total arterial revascularization using only arterial grafts. Suitable arterial grafts, however, are scarce and harvest procedures add to morbidity and cost. Tissue engineering combines the principles of engineering with life sciences for the development of biological substitutes and restore, maintain or improve tissue function. Advances in this field have included the development of tissue-engineered blood vessels, with the potential to serve as arterial grafts, conduits or fistulae. This review describes the history of tissue engineering arteries, the techniques used, and progress to date. The source of cells and the future direction of this field are explored.

[1]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[2]  A. Ratcliffe.  Tissue engineering of vascular grafts. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[3]  P. D’Amore,et al.  Mechanisms of endothelial growth control. , 1992, American journal of respiratory cell and molecular biology.

[4]  A. Vescovi,et al.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. , 1999, Science.

[5]  M. Crow,et al.  Vascular smooth muscle cell cultures. , 1997, Methods in cell biology.

[6]  Susan M. Drake.  A Novel Approach. , 1996 .

[7]  A Haverich,et al.  Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  Robert M. Nerem,et al.  Dynamic Mechanical Conditioning of Collagen-Gel Blood Vessel Constructs Induces Remodeling In Vitro , 2000, Annals of Biomedical Engineering.

[9]  T. Matsuda,et al.  Branched Hybrid Vessel: In Vitro Loaded Hydrodynamic Forces Influence the Tissue Architecture , 2000, Cell transplantation.

[10]  D. Dichek,et al.  Seeding of intravascular stents with genetically engineered endothelial cells. , 1989, Circulation.

[11]  J. Glover,et al.  A single-staged technique for seeding vascular grafts with autogenous endothelium. , 1978, Surgery.

[12]  L. Germain,et al.  A human tissue‐engineered vascular media: a new model for pharmacological studies of contractile responses , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Langer,et al.  A metalloproteinase inhibitor as an inhibitor of neovascularization , 1991, Journal of cellular biochemistry.

[14]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.

[15]  R Langer,et al.  Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.

[16]  C. Mullany,et al.  The role of gene therapy for intimal hyperplasia of bypass grafts. , 1999, Circulation.

[17]  K. Khabbaz,et al.  Clinical benefits of endoscopic vein harvesting in patients with risk factors for saphenectomy wound infections undergoing coronary artery bypass grafting. , 2000, The Journal of thoracic and cardiovascular surgery.

[18]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[19]  M. Karasek,et al.  Human dermal microvascular endothelial cells in vitro: Effect of cyclic AMP on cellular morphology and proliferation rate , 1981, Journal of cellular physiology.

[20]  R M Nerem,et al.  The study of the influence of flow on vascular endothelial biology. , 1998, The American journal of the medical sciences.

[21]  G. Sicard.  Seeding of intravascular stents with genetically engineered endothelial cells: Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Circulation 1989; 80: 1347-53 , 1990 .

[22]  R. Busuttil,et al.  Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? , 1988, Journal of vascular surgery.

[23]  T. Maciag,et al.  Serial propagation of human endothelial cells in vitro , 1981, The Journal of cell biology.

[24]  E. Edelman,et al.  Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. , 1999, Circulation research.

[25]  J. Campbell,et al.  Novel vascular graft grown within recipient's own peritoneal cavity. , 1999, Circulation research.

[26]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[27]  M. DeBakey,et al.  Surgical Considerations in the Treatment of Aneurysms of the Thoraco‐abdominal Aorta , 1965, Annals of surgery.

[28]  B. Davidson,et al.  Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[29]  P. Ma,et al.  Microtubular architecture of biodegradable polymer scaffolds. , 2001, Journal of biomedical materials research.

[30]  A. Banes,et al.  Differences in morphology, growth rate, and protein synthesis between cultured arterial and venous endothelial cells. , 1988, Journal of vascular surgery.

[31]  E. Weibel,et al.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA , 1964, The Journal of cell biology.

[32]  R. Nerem,et al.  Cyclic strain induces an oxidative stress in endothelial cells. , 1997, The American journal of physiology.

[33]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[34]  L. Bengtsson,et al.  Secretion of prostacyclin, tissue plasminogen activator and its inhibitor by cultured adult human endothelial cells grown on different matrices. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[35]  D. Dichek,et al.  Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. , 1998, Human gene therapy.

[36]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  R. Langer,et al.  Metalloproteinase inhibition as a mechanism for the inhibition of angiogenesis. , 1992, EXS.

[38]  E. Edelman,et al.  Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. , 2001, The Journal of surgical research.

[39]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[40]  E. Edelman,et al.  Tissue engineered perivascular endothelial cell implants regulate vascular injury. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. J. White,et al.  Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. , 2000, Circulation.

[42]  A. Sadikot,et al.  Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.

[43]  A. Evan,et al.  Endothelial seeding of Dacron and polytetrafluoroethylene grafts: the cellular events of healing. , 1984, Surgery.

[44]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[45]  J. Kardos,et al.  Mismatch of mechanical properties as a cause of arterial prostheses thrombosis. , 1976, Surgical forum.

[46]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[47]  E. Levine,et al.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.

[48]  A. Dominiczak,et al.  Analysis of Cell-Specific Promoters for Viral Gene Therapy Targeted at the Vascular Endothelium , 2001, Hypertension.

[49]  K. Kawachi,et al.  Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts. , 2001, The Journal of cardiovascular surgery.

[50]  J. Pelisek,et al.  Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[52]  R. Langer,et al.  Advances in tissue engineering of blood vessels and other tissues. , 1997, Transplant immunology.